ÂÜÀòÂÒÂ×

The Leadership Team at Mablink Bioscience is responsible for setting the strategic direction and vision of the company. They oversee the development and commercialization of innovative Antibody Drug Conjugates (ADCs) for cancer treatment, ensuring that financial, operational, and scientific objectives are met. This team collaborates to drive growth, maintain high-quality standards, and advance clinical development while fostering partnerships to enhance Mablink's impact in the biotechnology landscape.